Nano Biotechnology Market to reach USD 12.99 billion by 2032 and grow at a CAGR of 9.71%
The nano biotechnology market is revolutionizing healthcare through its applications in diagnostics, therapeutics, and public health innovations. A prominent example of its transformative impact is the use of lipid nanoparticles in developing mRNA vaccines during the COVID-19 pandemic, enabling high efficacy and rapid global deployment. These nanoparticles are now being explored for vaccines against infectious diseases and cancers.